Integra Lifesciences Holdings Corp (IART)
23.58
+0.58
(+2.52%)
USD |
NASDAQ |
Nov 22, 16:00
23.55
-0.03
(-0.13%)
After-Hours: 20:00
Integra Lifesciences Holdings Free Cash Flow: 38.04M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.04M |
| June 30, 2024 | 58.89M |
| March 31, 2024 | 60.93M |
| December 31, 2023 | 73.09M |
| September 30, 2023 | 109.75M |
| June 30, 2023 | 155.22M |
| March 31, 2023 | 199.56M |
| December 31, 2022 | 217.38M |
| September 30, 2022 | 188.30M |
| June 30, 2022 | 204.63M |
| March 31, 2022 | 232.22M |
| December 31, 2021 | 264.35M |
| September 30, 2021 | 274.39M |
| June 30, 2021 | 261.81M |
| March 31, 2021 | 203.05M |
| December 31, 2020 | 139.94M |
| September 30, 2020 | 155.10M |
| June 30, 2020 | 77.84M |
| March 31, 2020 | 82.80M |
| December 31, 2019 | 96.90M |
| September 30, 2019 | 46.91M |
| June 30, 2019 | 123.84M |
| March 31, 2019 | 109.20M |
| December 31, 2018 | 121.94M |
| September 30, 2018 | 102.79M |
| Date | Value |
|---|---|
| June 30, 2018 | 77.66M |
| March 31, 2018 | 77.49M |
| December 31, 2017 | 71.04M |
| September 30, 2017 | 58.53M |
| June 30, 2017 | 60.87M |
| March 31, 2017 | 74.63M |
| December 31, 2016 | 69.08M |
| September 30, 2016 | 96.28M |
| June 30, 2016 | 70.74M |
| March 31, 2016 | 59.29M |
| December 31, 2015 | 71.44M |
| September 30, 2015 | 72.05M |
| June 30, 2015 | 82.46M |
| March 31, 2015 | 71.12M |
| December 31, 2014 | 44.75M |
| September 30, 2014 | 38.72M |
| June 30, 2014 | 31.62M |
| March 31, 2014 | 13.89M |
| December 31, 2013 | 10.97M |
| September 30, 2013 | -24.22M |
| June 30, 2013 | -33.59M |
| March 31, 2013 | -34.84M |
| December 31, 2012 | -9.931M |
| September 30, 2012 | 39.80M |
| June 30, 2012 | 43.16M |
Free Cash Flow Range, Past 5 Years
38.04M
Minimum
Sep 2024
274.39M
Maximum
Sep 2021
154.71M
Average
155.16M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Haemonetics Corp | 20.35M |
| ResMed Inc | 1.347B |
| Globus Medical Inc | 293.77M |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 22.48M |
| Cash from Investing (Quarterly) | -10.40M |
| Cash from Financing (Quarterly) | -19.92M |
| Free Cash Flow Per Share (Quarterly) | -0.0937 |
| Free Cash Flow to Equity (Quarterly) | 11.54M |
| Free Cash Flow to Firm (Quarterly) | 0.3626M |
| Free Cash Flow Yield | 2.08% |